Christophe Passot - Publications

Analytical Validation of a Pan-Cancer Next-Generation Sequencing Assay for In-House Liquid Biopsy Testing: An International Multicenter Study.

Journal: The Journal of molecular diagnostics : JMD

Published: January 18, 2025

Learning to Train and to Explain a Deep Survival Model with Large-Scale Ovarian Cancer Transcriptomic Data.

Journal: Biomedicines

Published: November 25, 2024

PIPAC in patients with peritoneal metastases from gastrointestinal tract (PIPOX01): An open label, non-comparative phase 1/2 dose escalation and expansion trial.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: April 18, 2024

Comprehensive analyses of immune tumor microenvironment in papillary renal cell carcinoma.

Journal: Journal for immunotherapy of cancer

Published: October 19, 2023

Eculizumab dose tapering should take into account the nonlinearity of its pharmacokinetics.

Journal: British journal of clinical pharmacology

Published: October 18, 2023

Relationship Between Cetuximab Target-Mediated Pharmacokinetics and Progression-Free Survival in Metastatic Colorectal Cancer Patients.

Journal: Clinical pharmacokinetics

Published: May 28, 2023

Infliximab Efficacy May Be Linked to Full TNF-α Blockade in Peripheral Compartment-A Double Central-Peripheral Target-Mediated Drug Disposition (TMDD) Model.

Journal: Pharmaceutics

Published: September 14, 2021

Infliximab Treatment Does Not Lead to Full TNF-α Inhibition: A Target-Mediated Drug Disposition Model.

Journal: Clinical pharmacokinetics

Published: July 06, 2021

A letter of response to comments on 'A phase I dose-escalation study of oxaliplatin delivered via a laparoscopic approach using pressurised intraperitoneal aerosol chemotherapy for advanced peritoneal metastases of gastrointestinal tract cancers'.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 27, 2020

Functional pre-therapeutic evaluation by genome editing of variants of uncertain significance of essential tumor suppressor genes.

Journal: Genome medicine

Published: May 20, 2020

Feasibility and safety of tailored dosing schedule for eculizumab based on therapeutic drug monitoring: Lessons from a prospective multicentric study.

Journal: British journal of clinical pharmacology

Published: April 07, 2020

A phase I dose-escalation study of oxaliplatin delivered via a laparoscopic approach using pressurised intraperitoneal aerosol chemotherapy for advanced peritoneal metastases of gastrointestinal tract cancers.

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 28, 2020